RotationRx · Drugs · Scores · Protocols · Diagnoses · Specialties

← Drug Reference

Losartan

Hypertension, Reduction of the risk of stroke in patients with hypertension and left ventricular..., Treatment of diabetic nephropathy

Boxed warning

  • WARNING: FETAL TOXICITY When pregnancy is detected, discontinue losartan potassium as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing fetus [see Warnings and Precautions (5.1) ]. WARNING: FETAL TOXICITY See full prescribing information for complete boxed warning. When pregnancy is detected, discontinue losartan potassium as soon as possible. Drugs that act directly on the renin-angiotensin system can cause injury and death to the developing ... (see full label)

Indications

  • Hypertension
  • Reduction of the risk of stroke in patients with hypertension and left ventricular...
  • Treatment of diabetic nephropathy

Adult dosing

  • hypertension: dose: 50; unit: mg; route: PO; interval: once daily; fixed: true; labelExcerpt: Usual adult dose: 50 mg once daily.
  • diabetic nephropathy: dose: 50; unit: mg; route: PO; interval: once daily; increase to 100 mg once daily for BP; fixed: true; labelExcerpt: Nephropathy in Type 2 Diabetic Patients • Usual dose: 50 mg once daily.

Pediatric dosing

  • hypertension: dose: 0.7; unit: mg/kg; route: PO; interval: once daily (starting dose); weightBased: true; maxDose: 50; maxDoseAbsolute: true; labelExcerpt: Usual pediatric starting dose: 0.7 mg per kg once daily (up to 50 mg).

Renal adjustment

  • Consult pharmacy/current label

Hepatic adjustment

  • Recommended starting dose 25 mg once daily for mild-to-moderate impairment.

Contraindications

  • Hypersensitivity
  • Coadministration with aliskiren in patients with diabetes

Clinical pearls

  • Monitor renal function and serum potassium periodically.
  • Correct volume or salt depletion prior to initiation to prevent symptomatic hypotension.
  • Not recommended in children <6 years or those with GFR <30 mL/min/1.73 m2.

Source and review

  • DailyMed label (losartan potassium), Set ID 021cd76a-b093-4704-8410-5e7d01e20a54, effective 2026-08-27. Last reviewed: 2026-11-11